PROCEPT BioRobotics (PRCT) Current Deferred Revenue (2020 - 2025)
PROCEPT BioRobotics has reported Current Deferred Revenue over the past 6 years, most recently at $13.0 million for Q4 2025.
- Quarterly results put Current Deferred Revenue at $13.0 million for Q4 2025, up 36.41% from a year ago — trailing twelve months through Dec 2025 was $13.0 million (up 36.41% YoY), and the annual figure for FY2025 was $13.0 million, up 36.41%.
- Current Deferred Revenue for Q4 2025 was $13.0 million at PROCEPT BioRobotics, up from $10.7 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for PRCT hit a ceiling of $13.0 million in Q4 2025 and a floor of $848000.0 in Q3 2021.
- Median Current Deferred Revenue over the past 5 years was $5.3 million (2023), compared with a mean of $5.7 million.
- Biggest five-year swings in Current Deferred Revenue: soared 339.91% in 2021 and later surged 33.5% in 2025.
- PROCEPT BioRobotics' Current Deferred Revenue stood at $1.0 million in 2021, then soared by 178.54% to $2.9 million in 2022, then surged by 98.11% to $5.7 million in 2023, then surged by 69.11% to $9.6 million in 2024, then skyrocketed by 36.41% to $13.0 million in 2025.
- The last three reported values for Current Deferred Revenue were $13.0 million (Q4 2025), $10.7 million (Q3 2025), and $9.9 million (Q2 2025) per Business Quant data.